Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats
- PMID: 487124
- DOI: 10.1016/0006-8993(79)90804-7
Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats
Abstract
The role of brain serotonin in regulating prolactin (PRL) secretion has been investigated by studying the effect of quipazine and D-fenfluramine, two serotonin-like drugs, on plasma PRL levels under various experimental conditions. Quipazine (5, 10 and 20 mg/kg i.p.) and D-fenfluramine (5, 7.5 and 10 mg/kg i.p.) induced dose-related increases in plasma PRL levels in male rats. Intraventricular injection of 5,7-dihydroxytryptamine (5,7-DHT) or electrolytic lesion of the nucleus raphe medianus (MR), which caused a marked and selective depletion of hypothalamic serotonin levels, significantly reduced the PRL-releasing effect of both quipazine and D-fenfluramine. These results suggest that the effect of these drugs on PRL release is mediated through a serotonergic mechanism in the brain.
Similar articles
-
Circling produced by serotonin and dopamine agonists in raphe lesioned rats: a serotonin model.Pharmacol Biochem Behav. 1980 Dec;13(6):817-21. doi: 10.1016/0091-3057(80)90213-0. Pharmacol Biochem Behav. 1980. PMID: 7193875
-
Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.Pharmacol Biochem Behav. 1984 May;20(5):739-45. doi: 10.1016/0091-3057(84)90193-x. Pharmacol Biochem Behav. 1984. PMID: 6610879
-
Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.Psychopharmacology (Berl). 1981;73(2):188-93. doi: 10.1007/BF00429216. Psychopharmacology (Berl). 1981. PMID: 6785814
-
Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.Brain Res. 1982 Oct 14;249(2):291-9. doi: 10.1016/0006-8993(82)90063-4. Brain Res. 1982. PMID: 6291713
-
Some behavioral effects of serotonin depletion depend on method: a comparison of 5,7-dihydroxytryptamine, p-chlorophenylalanine, p-choloroamphetamine, and electrolytic raphe lesions.Ann N Y Acad Sci. 1978 Jun 12;305:532-55. doi: 10.1111/j.1749-6632.1978.tb31547.x. Ann N Y Acad Sci. 1978. PMID: 152081 Review. No abstract available.
Cited by
-
The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions.Ann Gen Psychiatry. 2010 Apr 12;9:14. doi: 10.1186/1744-859X-9-14. Ann Gen Psychiatry. 2010. PMID: 20385020 Free PMC article.
-
5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.Psychopharmacology (Berl). 1996 Sep;127(2):108-12. doi: 10.1007/BF02805982. Psychopharmacology (Berl). 1996. PMID: 8888375 Clinical Trial.
-
5-Hydroxytryptophan-stimulated prolactin levels in cafeteria diet fed rats: an in vivo evaluation of the central serotonergic tonus.J Endocrinol Invest. 1994 Nov;17(10):783-6. doi: 10.1007/BF03347775. J Endocrinol Invest. 1994. PMID: 7699211
-
5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects.Psychopharmacology (Berl). 1996 Jul;126(1):24-30. doi: 10.1007/BF02246407. Psychopharmacology (Berl). 1996. PMID: 8853213 Clinical Trial.
-
Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion.J Neural Transm. 1984;59(2):143-9. doi: 10.1007/BF01255412. J Neural Transm. 1984. PMID: 6233394
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
